GATA1 mutations in Down Syndrome: Implications for biology and diagnosis of children with transient myeloproliferative disorder and acute megakaryoblastic leukemia
- 1 January 2004
- journal article
- review article
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 44 (1), 40-44
- https://doi.org/10.1002/pbc.20066
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Recent insights into the mechanisms of myeloid leukemogenesis in Down syndromeBlood, 2004
- Frequent mutations in the GATA-1 gene in the transient myeloproliferative disorder of Down syndromeBlood, 2003
- GATA1 mutations in transient leukemia and acute megakaryoblastic leukemia of Down syndromeBlood, 2003
- Mutagenesis of GATA1 is an initiating event in Down syndrome leukemogenesisBlood, 2003
- Acquired mutations in GATA1 in neonates with Down's syndrome with transient myeloid disorderThe Lancet, 2003
- Mutations in exon 2 of GATA1 are early events in megakaryocytic malignancies associated with trisomy 21Blood, 2003
- Acquired mutations in GATA1 in the megakaryoblastic leukemia of Down syndromeNature Genetics, 2002
- The Management of Neoplastic Disorders of Haematopoeisis in Children with Down's SyndromeBritish Journal of Haematology, 2000
- A lineage-selective knockout establishes the critical role of transcription factor GATA-1 in megakaryocyte growth and platelet developmentThe EMBO Journal, 1997
- Alternative translation initiation site usage results in two functionally distinct forms of the GATA-1 transcription factor.Proceedings of the National Academy of Sciences, 1995